zolpidem has been researched along with Pain, Chronic in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zolpidem (Ambien(®)) is the most prescribed insomnia treatment in the USA; however, little is known about zolpidem metabolite excretion in chronic pain patients." | 7.80 | Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patients. ( Black, DL; Caplan, YH; Cone, EJ; DePriest, A; Heltsley, R; Schwope, DM, 2014) |
| "Zolpidem (Ambien(®)) is the most prescribed insomnia treatment in the USA; however, little is known about zolpidem metabolite excretion in chronic pain patients." | 3.80 | Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patients. ( Black, DL; Caplan, YH; Cone, EJ; DePriest, A; Heltsley, R; Schwope, DM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwope, DM | 1 |
| DePriest, A | 1 |
| Black, DL | 1 |
| Caplan, YH | 1 |
| Cone, EJ | 1 |
| Heltsley, R | 1 |
1 other study available for zolpidem and Pain, Chronic
| Article | Year |
|---|---|
Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patients.
Topics: Chromatography, Liquid; Chronic Pain; Humans; Hypnotics and Sedatives; Limit of Detection; Pyridines | 2014 |